Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02368379 · ClinicalTrials.gov registry record · NA
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02368379 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 23 participants.
The verdict
NCT02368379, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test.
Interventions
- OTHER Low dose (1 mcg) ACTH stimulation test
- OTHER Overnight metyrapone test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02368379
The ClinicalTrials.gov registry entry for NCT02368379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low dose (1 mcg) ACTH stimulation test is the first listed.
NCT02368379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02368379 about?
NCT02368379 is a clinical study titled "Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome". The purpose of this study is to determine presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test.
What is the current status of trial NCT02368379?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-03. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02368379?
The interventions under investigation include: Low dose (1 mcg) ACTH stimulation test (OTHER), Overnight metyrapone test (OTHER).
Who is sponsoring clinical trial NCT02368379?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.